D
Dominique Figarella-Branger
Researcher at Aix-Marseille University
Publications - 583
Citations - 39329
Dominique Figarella-Branger is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Medicine & Glioma. The author has an hindex of 80, co-authored 543 publications receiving 30147 citations. Previous affiliations of Dominique Figarella-Branger include Centre national de la recherche scientifique & University of the Mediterranean.
Papers
More filters
Journal ArticleDOI
MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma.
Franck Bourdeaut,Franck Bourdeaut,Camille Grison,Claude-Alain Maurage,Annie Laquerrière,Alexandre Vasiljevic,Marie-Bernadette Delisle,Sophie Michalak,Dominique Figarella-Branger,François Doz,François Doz,Wilfrid Richer,Gaëlle Pierron,Catherine Miquel,Olivier Delattre,Olivier Delattre,Jérôme Couturier,Jérôme Couturier +17 more
TL;DR: Given its cost efficiency in comparison to two FISH tests and the global genomic information additionally provided by an aCGH experiment, this reproducible technique can be safely retained as an alternative to FISH for routine investigation of medulloblastoma.
Journal ArticleDOI
IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas.
Romain Appay,Emeline Tabouret,Nicolas Macagno,Mehdi Touat,Catherine Carpentier,Carole Colin,Carole Colin,François Ducray,Ahmed Idbaih,Karima Mokhtari,Emmanuelle Uro-Coste,Caroline Dehais,Dominique Figarella-Branger +12 more
TL;DR: Data is analyzed from 1517 patients included in the French POLA Network to investigate differences between IDH1-and IDH2-mutant gliomas, and it is unclear whether these tumors share the same characteristics.
Journal ArticleDOI
Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Christian Carrie,Virginie Kieffer,Dominique Figarella-Branger,Julien Masliah-Planchon,Stéphanie Bolle,Valérie Bernier,Anne Laprie,Stéphane Supiot,Julie Leseur,Jean-Louis Habrand,Claire Alapetite,Christine Kerr,Christelle Dufour,Line Claude,Sophie Chapet,Aymeri Huchet,Pierre-Yves Bondiau,Alexandre Escande,Gilles Truc,Tan Dat Nguyen,Caroline Pasteuris,Céline Vigneron,Xavier Muracciole,Franck Bourdeaut,Romain Appay,Bernard Dubray,Carole Colin,Celine Ferlay,Sophie Dussart,Sylvie Chabaud,Laetitia Padovani +30 more
TL;DR: IQ is more preserved in children with standard-risk medulloblastoma who received exclusive HFRT and reduced local boost, IQ decline is delayed compared with patients receiving standard regimen, and cognitive evaluations based on Wechsler scale are presented.
Journal ArticleDOI
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
Carine Jiguet-Jiglaire,Sébastien Boissonneau,Emilie Denicolai,Vera Hein,Romain Lasseur,Josep Garcia,S. Romain,Romain Appay,Thomas Graillon,Warren P. Mason,Antoine F. Carpentier,Alba A. Brandes,L'Houcine Ouafik,Wolfgang Wick,Ania I. Baaziz,Julien-Paul Gigan,Rafael J. Argüello,Dominique Figarella-Branger,Olivier Chinot,Emeline Tabouret +19 more
TL;DR: In this article , a randomized phase III trial was conducted to evaluate the predictive value of matrix metalloproteinase 2 and MMP9 in patients with newly diagnosed glioblastoma and explore their tumor source.
Journal ArticleDOI
Fetal visceral maturation: a useful contribution to gestational age estimation in human fetuses.
Marie-Dominique Piercecchi-Marti,Pascal Adalian,Agnès Liprandi,Dominique Figarella-Branger,Olivier Dutour,Georges Leonetti +5 more
TL;DR: It is demonstrated that adrenal glands and skin were very good age indicators, because some characteristics appeared only after 20 weeks, and the pathologist must use both histological and anthropometric data to determine fetal age as accurately as possible.